Safety and Efficacy of Intravenous Natalizumab in Acute Ischemic Stroke
Completed · Phase 2 · Has a placebo group
Conditions studied: Acute Ischemic Stroke
In brief
The primary objective of the study is to assess the clinical effects of natalizumab versus placebo in acute ischemic stroke on clinical measures of functional independence and activities of daily living. The secondary objective of the study is to explore dose and exposure response and the clinical treatment effects of natalizumab versus placebo in acute ischemic stroke on the following: measures of independence, activities of daily living, neurologic function, quality of life, cognition, and safety and tolerability
Key facts
- Study ID
- NCT02730455
- Run by
- Biogen
- People needed
- 277
- Starts
- 2016-07-18
- Expected to finish
- 2017-11-20
- Last updated by the study team
- 2019-01-08
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Sacramento, California, United States
- Research Site — San Diego, California, United States
- Research Site — Washington D.C., District of Columbia, United States
- Research Site — Gainesville, Florida, United States
- Research Site — Fort Wayne, Indiana, United States
- Research Site — Boston, Massachusetts, United States
- Research Site — St Louis, Missouri, United States
- Research Site — New York, New York, United States
- Research Site — Durham, North Carolina, United States
- Research Site — Columbus, Ohio, United States
- Research Site — Portland, Oregon, United States
- Research Site — Portland, Oregon, United States
- Research Site — Portland, Oregon, United States
- Research Site — Abington, Pennsylvania, United States
- Research Site — Philadelphia, Pennsylvania, United States
- Research Site — Charleston, South Carolina, United States
- Research Site — Knoxville, Tennessee, United States
- Research Site — Altenburg, Germany
- Research Site — Bad Neustadt/Saale, Germany
- Research Site — Bamberg, Germany
- Research Site — Bergisch Gladbach, Germany
- Research Site — Dresden, Germany
- Research Site — Dresden, Germany
- Research Site — Düsseldorf, Germany
- Research Site — Los Angeles, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.